Not applicableStudy completedNCT01236053What this trial is testingCancer in Patients With Gabapentin (GPRD)Who this might be right forPain, NeuropathicEpilepsyRenal Pelvis Cancer+13 more GlaxoSmithKline 2,323,608
Not applicableUnknownNCT05662839What this trial is testingFeasibility of Utilising Brushing Cytology and Dermoscopy for Diagnosing Penile LesionsWho this might be right forPenile Cancer The Christie NHS Foundation Trust 50
Early research (Phase 1)Looking for participantsNCT07217171What this trial is testingA Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell CarcinomasWho this might be right forBladder CancerSquamous Cell Carcinoma of the LungEsophageal Squamous Cell Carcinoma+8 more EvolveImmune United, Inc 160
Not applicableActive Not RecruitingNCT05946993What this trial is testingLinking In With Advice and Supports for Men Impacted by Metastatic CancerWho this might be right forSurvivorshipProstate CancerKidney Cancer+3 more University College Cork 72
Testing effectiveness (Phase 2)Looking for participantsNCT05686226What this trial is testingE7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated CancersWho this might be right forCervical CancerThroat CancerOropharynx Cancer+18 more Christian Hinrichs 20
Not applicableStudy completedNCT03346915What this trial is testingIntegrating a Health Information Technology System for Primary and Secondary Cervical Cancer PreventionWho this might be right forHuman Papilloma VirusCervical CancerHuman Papillomavirus Infection+5 more Boston Medical Center 60
Early research (Phase 1)Study completedNCT00019110What this trial is testingVaccine Therapy in Treating Patients With Advanced or Recurrent CancerWho this might be right forAnal CancerCervical CancerEsophageal Cancer+3 more National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Active Not RecruitingNCT03391479What this trial is testingAvelumab in Penile Cancer Who Are Unfit for or Have Progressed After Platinum-Based ChemotherapyWho this might be right forPenile CancerAdvanced CancerMetastatic Cancer University Health Network, Toronto 25
Testing effectiveness (Phase 2)Study completedNCT00512096What this trial is testingNeoadjuvant Chemotherapy for Patients With Squamous Cell Carcinoma of the PenisWho this might be right forPenile Cancer M.D. Anderson Cancer Center 30
Early research (Phase 1)Active Not RecruitingNCT02496208What this trial is testingCabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary TumorsWho this might be right forBladder Small Cell Neuroendocrine CarcinomaBladder Squamous Cell CarcinomaBladder Urothelial Carcinoma+27 more National Cancer Institute (NCI) 152
Testing effectiveness (Phase 2)Ended earlyNCT03439085What this trial is testingDNA Plasmid-encoding Interleukin-12/HPV DNA Plasmids Therapeutic Vaccine INO-3112 and Durvalumab in Treating Patients With Recurrent or Metastatic Human Papillomavirus Associated CancersWho this might be right forHuman Papillomavirus-16 PositiveHuman Papillomavirus-18 PositiveMetastatic Malignant Neoplasm+18 more M.D. Anderson Cancer Center 41
Testing effectiveness (Phase 2)Looking for participantsNCT07518979What this trial is testingEGFR-ADC (Becotatug Vedotin) Combined With PD-1 Inhibitor (Pucotenlimab) in Neoadjuvant Treatment of Advanced Penile CancerWho this might be right forPenile Cancer Jiyan Liu 60
Early research (Phase 1)Study completedNCT00003704What this trial is testingChemotherapy Plus Radiation Therapy in Treating Patients With Unresectable, Residual, or Recurrent Colorectal CancerWho this might be right forCancer Alliance for Clinical Trials in Oncology 51
Testing effectiveness (Phase 2)Active Not RecruitingNCT03333616What this trial is testingNivolumab Combined With Ipilimumab for Patients With Advanced Rare Genitourinary TumorsWho this might be right forGenitourinary CancerAdrenocortical CarcinomaNon-urothelial Bladder+5 more Dana-Farber Cancer Institute 100
Not applicableStudy completedNCT04028479What this trial is testingThe Registry of Oncology Outcomes Associated With Testing and TreatmentWho this might be right forAdenocarcinomaAdenocystic CarcinomaAnal Cancer+73 more Taproot Health 167
Testing effectiveness (Phase 2)Looking for participantsNCT06104618What this trial is testingEnfortumab Vedotin for the Treatment of Patients With Metastatic or Unresectable Squamous Cell Carcinoma of the PenisWho this might be right forMetastatic Penile Squamous Cell CarcinomaStage III Penile Cancer AJCC v8Stage IV Penile Cancer AJCC v8+1 more Mayo Clinic 28
Not applicableLooking for participantsNCT04923178What this trial is testingA Multi-Center Natural History of Urothelial Cancer and Rare Genitourinary Tract MalignanciesWho this might be right forUrothelial CancerBladder CancerGenitourinary Cancer+2 more National Cancer Institute (NCI) 1,100
Testing effectiveness (Phase 2)Looking for participantsNCT07497919What this trial is testingBecotatug Vedotin Combined With Pucotenlimab in the Treatment of EGFR-Positive Advanced Penile CancerWho this might be right forPenile Cancer Fudan University 20
Testing effectiveness (Phase 2)UnknownNCT03221400What this trial is testingPEN-866 in Patients With Advanced Solid MalignanciesWho this might be right forCarcinomaEndometrial AdenocarcinomaNeoplasms+16 more Tarveda Therapeutics 340
Testing effectiveness (Phase 2)Looking for participantsNCT05969860What this trial is testingAt-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced CancerWho this might be right forAdvanced Anal CarcinomaAdvanced Biliary Tract CarcinomaAdvanced Bladder Carcinoma+41 more Mayo Clinic 220